Related references
Note: Only part of the references are listed.Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
Jenny Klintman et al.
BLOOD (2021)
Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
Maryam Ahmed Al Barashdi et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas
Huanyu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades
Xiaoyan Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity
Xinyue Song et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
Qinghua Wang et al.
AGING-US (2020)
Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis
Sreekanth Chanickal Narayanapillai et al.
CARCINOGENESIS (2020)
Protein tyrosine phosphatase receptor type D (PTPRD)—mediated signaling pathways for the potential treatment of hepatocellular carcinoma: a narrative review
Xuejing Huang et al.
Annals of Translational Medicine (2020)
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
Zifan He et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer (vol 33, pg 853, 2018)
Matthew D. Hellmann et al.
CANCER CELL (2019)
Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients
Pengguang Yan et al.
INFLAMMATORY BOWEL DISEASES (2019)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types
Feng Wang et al.
JAMA ONCOLOGY (2019)
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
David A. Braun et al.
JAMA ONCOLOGY (2019)
Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma
Chao Chen et al.
SCIENTIFIC REPORTS (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
Khadijah A. Mitchell et al.
NATURE COMMUNICATIONS (2019)
Titin mutation associated with responsiveness to checkpoint blockades in solid tumors
Qingzhu Jia et al.
JCI INSIGHT (2019)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Xiangchun Li et al.
JAMA ONCOLOGY (2018)
PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
Hung-Chih Hsu et al.
CANCERS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
M. Choi et al.
ANNALS OF ONCOLOGY (2017)
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong et al.
CLINICAL CANCER RESEARCH (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Jaegil Kim et al.
NATURE GENETICS (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Oncotator: Cancer Variant Annotation Tool
Alex H. Ramos et al.
HUMAN MUTATION (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin et al.
NATURE IMMUNOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
Mihaela Angelova et al.
GENOME BIOLOGY (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clonal Architectures and Driver Mutations in Metastatic Melanomas
Li Ding et al.
PLOS ONE (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
Srikanth Nagalla et al.
GENOME BIOLOGY (2013)
Regulatory T Cells Enhance Mast Cell Production of IL-6 via Surface-Bound TGF-β
Kirthana Ganeshan et al.
JOURNAL OF IMMUNOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Tumour suppressor function of protein tyrosine phosphatase receptor-T
Anthony Scott et al.
BIOSCIENCE REPORTS (2011)
IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression
Kathrin Eller et al.
JOURNAL OF IMMUNOLOGY (2011)
Genomic instability and the selection of treatments for cancer
Sarah A. Martin et al.
JOURNAL OF PATHOLOGY (2010)
Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment
Yujin Hoshida
PLOS ONE (2010)
Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T
Yiqing Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-induced EMT of Cancer Cells
Chie Kudo-Saito et al.
CANCER CELL (2009)
Molecular Mechanisms of IFN-gamma to Up-Regulate MHC Class I Antigen Processing and Presentation
Fang Zhou
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
Protein tyrosine phosphatases in the JAK/STAT pathway
Dan Xu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Protein tyrosine phosphatase α regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts
L Maksumova et al.
JOURNAL OF IMMUNOLOGY (2005)
Receptor protein tyrosine phosphatase ζ as a therapeutic target for glioblastoma therapy
S Müller et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Share Paper
